PALI compared with IVVD: revenue, margins and what each company keeps, and the suppliers and customers both name

PALIPalisade Bio, Inc.

Mkt capRevenueRevenue

IVVDInvivyd, Inc.

Mkt capRevenueRevenue

Compare

PALIPalisade Bio, Inc.

IVVDInvivyd, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PALI1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+1.90%—

IVVD1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±48.9%▲+5.13%×0.10

= impliedPALI realized, solidIVVD realized, hatchedOne scale, both sides: full bar = 49%× = |realized| ÷ impliedSource: market data

PALIPalisade Bio, Inc.

1.14▼−2.14%· post 1.14

Mkt cap$196.9MRevenue$500,000Q2 FY26Revenue—

IVVDInvivyd, Inc.

0.56▼−4.10%· post 0.56

ClosedNov 6 '26

Mkt cap$165.9MRevenue$14MQ2 FY26Revenue$53MFY25

Compare

ClosedNov 6 '26

PALIPalisade Bio, Inc.

IVVDInvivyd, Inc.

1.14▼−2.14%post 1.14

Price

0.56▼−4.10%post 0.56

$196.9M

Mkt cap

$165.9M

Q2 FY26$500,000

Revenue

$14MQ2 FY26

—

Revenue

$53MFY25

PALI1.14▼−2.14%vsIVVD0.56▼−4.10%ClosedNov 6 '26